首页 / 院系成果 / 成果详情页

Hyperlipidemia as adverse event of lorlatinib, a multicenter cohort study.  会议论文  

  • 编号:
    48420C4F4A9FFEC6BAC4C1B4170642B9
  • 作者:
    Xu, Fei ;Cheng, Yuan ;Wang, Yan ;Xin, Tao ;Jin, Bo ;Fang, Jian ;Liang, Li ;Li, Xiaoyan ;Tang, Chuanhao ;Liu, Yonggang ;Cui, Huijuan ;Yan, Dong ;Li, Lin ;Zhang, Yuhui ;Zhang, Li ;Zhou, Yunzhi ;Mu, Xin Lin
  • 语种:
    英文
  • 会议名称:
    JOURNAL OF CLINICAL ONCOLOGY
  • 收录:
  • 关键词:
  • 推荐引用方式
    GB/T 7714:
    Xu Fei,Cheng Yuan,Wang Yan, et al. Hyperlipidemia as adverse event of lorlatinib, a multicenter cohort study. [J].JOURNAL OF CLINICAL ONCOLOGY,2025,43(16_SUPPL):e24040-e24040.
  • APA:
    Xu Fei,Cheng Yuan,Wang Yan,Xin Tao,&Mu Xin Lin.(2025).Hyperlipidemia as adverse event of lorlatinib, a multicenter cohort study. .JOURNAL OF CLINICAL ONCOLOGY,43(16_SUPPL):e24040-e24040.
  • MLA:
    Xu Fei, et al. "Hyperlipidemia as adverse event of lorlatinib, a multicenter cohort study." .JOURNAL OF CLINICAL ONCOLOGY 43,16_SUPPL(2025):e24040-e24040.
  • 入库时间:
    2026/2/25 8:31:44
  • 更新时间:
    2026/2/25 8:31:44
浏览次数:10 下载次数:0
浏览次数:10
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部